期刊文献+

溶血磷脂酰胆碱衍生物的合成及其对自然杀伤T细胞的激活作用

Synthesis of Immunostimulant Lysophosphatidylcholine Analogues and Their Agonist Activities for Natural Killer T Cells
下载PDF
导出
摘要 溶血磷脂酰乙醇胺(pLPE)是自然杀伤T细胞(NKT)的内源性抗原。溶血磷脂酰胆碱衍生物(LPC)与CD1d结合被NKT细胞识别并激活NKT细胞。本文以手性甘油醇缩丙酮为起始原料,合成了LPC衍生物(5和6),其结构经~1H NMR,^(13)C NMR,^(31)P NMR和HR-MS(ESI)确证。研究了5和6的免疫活性。结果表明:100 ng·mL^(-1)6负载mCD1d分子后可刺激2H4细胞释放IL-2因子(32.13±1.56 pg·mL^(-1)),具有潜在的NKT激活性质。 Plasmalogen lysophosphatidylethanolamines(pLPE),had been found as self antigens for natural killer T cells(NKT cells).Lysophosphatidylcholines(LPC)was reported to be recognized by NKT cells as antigens presented by CD1d.Two LPC derivatives(5 and 6)were synthesized using 2,3-O-isopropylidene-sn-glycerol as material.The structures were confirmed by^1 H NMR,^13 C NMR,^31 P NMR and HR-MS(ESI).The immunocompetence of 5 and 6 were investigated.The results showed that 100 ng·mL^-1 6 loaded with plate-bound mCD1d stimulated NKT 2H4 cells to release IL-2(32.13±1.56 pg·mL^-1).The compound 6 was a potential new NKT agonist.
作者 倪广惠 卫舒帆 李志远 夏成峰 NI Guang-hui;WEI Shu-fan;LI Zhi-yuan;XIA Cheng-feng(College of Pharmaceutic Science,Yunnan University of Chinese Medicine,Kunming 650500,China;Key Laboratory,Department of Otolaryngology-head and Neck Surgery,Affiliated Hospital of Qingdao University,Qingdao 266003,China;Key Laboratory of Medicinal Chemistry for Natural Resources,Ministry of Education,Yunnan University,Kunming 650091,China)
出处 《合成化学》 CAS 北大核心 2019年第2期114-118,共5页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(81560558) 云南应用基础研究-中医联合专项(2015FB205-029)
关键词 自然杀伤T细胞 溶血磷脂类化合物 溶血磷脂酰胆碱 合成 免疫活性 nature killer T cell lysophospholipid lysophosphatidylcholine synthesis immunocompetence
  • 相关文献

参考文献1

二级参考文献76

  • 1Natori, T.; Morita, M.; Akimoto, K.; Koezuka, Y. Tetrahedron 1994, 50, 2771.
  • 2Uchida, T.; Horiguchi, S.; Tanaka, Y.; Yamamoto, H.; Kunii, N.; Motohashi, S.; Taniguchi, M.; Nakayama, T.; Okamoto, Y. Cancer Immunol. lmmun. 2008, 57, 337.
  • 3Chackerian, A., Alt, J.; Perera, V.; Behar, S, M. Infect. Immun. 2002, 70, 6302.
  • 4Hung, J.-T. Tsai, Y.-C.; Lin, W.-D.; Jan, J.-T.; Lin, K.-H.; Huang, J.-R.; Cheng, J.-Y.; Chen, M.-W.; Wong, C.-H.; Yu, A. L. Antiviral Res. 2014, 107, 110.
  • 5Kawakami, K.; Kinjo, Y,; Yara, S.; Koguchi, Y.; Uezu, K.; Nakayama, T.; Tanigushi, M.; Saito, A. Infect. lmmun. 2001, 69, 213.
  • 6Dieli, F.; Taniguchi, M.; Kronenberg, M.; Sidobre, S.; Ivanyi, J.; Fattorini, L.; lona, E.; Orefici, G.; Leo, G. D.; Russo, D; Caccamo, N.; Sireci, G.; Sano, C. D.; Salerno, A. J. Immunol. 2003, 171, 1961.
  • 7Singh, A. K.; Yang, J.-Q.; Parekh, V. V.; Wei, J.; Wang, C.-R.; Joyce, S.; Singh, R. R.; Kaer, L. V. Eur. J. Immunol. 2005, 35, 1143.
  • 8Duarte, N.; Stenstrom, M.; Campino, S.; Bergman, M.-L.; Lundholm, M.; Holmberg, D.; Cardell, S. L. J. Immunol. 2004, 173,3112.
  • 9Kobayashi, E.; Motoki, K.; Yamaguchi, Y.; Uchida, T.; Fukushima, H.; Koezuka, Y. Bioorg. Med. Chem. Lett. 1996, 4, 615.
  • 10Motohashi, S.; Nagato, K.; Kunii, N.; Yamamoto, H.; Yamasaki, K.; Okita, K.; Hanaoka, H.; Shimizu, N.; Suzuki, M.; Yoshino, 1.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部